Company news

Share this article:
Wyeth is spending $280 million on a manufacturing plant in China, the company said. The plant, to be built at Suzhou Industrial Park in Jiangsu Province, is to produce milk powder for infant formula “and other nutritional products” for distribution in the region.  Wyeth said the plant will employ about 500 people.

Group dca, has launched a new consumer division called cue. The cue division was created in response to the growing non-adherence crisis and the pharmaceutical industry's need for a better way to reach, teach, and guide patients over time so that they take their medications and stay on them as prescribed, the agency said.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.